0001564590-19-006999 Sample Contracts

CONFIDENTIAL
Separation Agreement and Release • March 8th, 2019 • Proteostasis Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
Sample 1Sample 2Sample 3See All (7)
AutoNDA by SimpleDocs
Technology Transfer and License Agreement between Genentech, Inc. and Proteostasis Therapeutics, Inc.
Technology Transfer and License Agreement • March 8th, 2019 • Proteostasis Therapeutics, Inc. • Pharmaceutical preparations • Delaware

This Technology Transfer and License Agreement (“Agreement”) is made and entered into, effective as of December 13, 2018 (“Effective Date”), by and between Genentech, Inc., a Delaware corporation, having a principal place of business at 1 DNA Way, South San Francisco, California 94080 (“Genentech”) and Proteostasis Therapeutics, Inc. , a Delaware corporation, having a principal place of business at 80 Guest Street, Suite 500, Boston, MA 02135 (“PTI”). Genentech and PTI are each referred to herein individually as a “Party” and collectively as the “Parties.”

Sample 1
October 19, 2018 Proteostasis Therapeutics, Inc.
Proteostasis Therapeutics, Inc. • March 8th, 2019 • Pharmaceutical preparations
Sample 1
Time is Money Join Law Insider Premium to draft better contracts faster.